Exploratory analysis of immunochemotherapy compared to chemotherapy after EGFR‐TKI in non–small cell lung cancer patients with EGFR mutation: A multicenter retrospective study

Autor: Tae Hata, Chikara Sakaguchi, Keita Hirano, Hiroshi Kobe, Masaki Ishida, Takayuki Nakano, Yusuke Tachibana, Nobuyo Tamiya, Shinsuke Shiotsu, Takayuki Takeda, Tadaaki Yamada, Toshihide Yokoyama, Michiko Tsuchiya, Yukio Nagasaka

Publikováno v: Thoracic Cancer, Vol 14, Iss 11, Pp 1004-1011 (2023)

Abstract Background Patients with epidermal growth factor receptor (EGFR)‐mutated, advanced non–small cell lung cancer have received immunochemotherapy as one of the treatment options after tyrosine kinase inhibitor (TKI) failure. Methods We retr

Externí odkaz: https://doaj.org/article/4d514c461e6642988de42d18d2872f6d

Efficacy and safety of immuno-chemotherapy in patients with advanced non-small-cell lung cancer harboring oncogenic mutations: a multicenter retrospective study

Autor: Tae, Hata, Chikara, Sakaguchi, Keita, Hirano, Hiroshi, Kobe, Masaki, Ishida, Takayuki, Nakano, Yusuke, Tachibana, Nobuyo, Tamiya, Shinsuke, Shiotsu, Takayuki, Takeda, Tadaaki, Yamada, Toshihide, Yokoyama, Michiko, Tsuchiya, Yukio, Nagasaka

Publikováno v: Journal of Cancer Research and Clinical Oncology. 149:2475-2482

The effect of immuno-chemotherapy on patients with advanced non-small-cell lung cancer (NSCLC) harboring oncogenic mutations remains poorly understood. This study aimed to characterize the efficacy of immuno-chemotherapy and determine the optimal tre

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6168b054544d9d273703f8d98b61f41c
https://doi.org/10.1007/s00432-022-04125-8

A Prospective Cohort Study to Define the Clinical Features and Outcome of Lung Cancers Harboring HER2 Aberration in Japan (HER2-CS STUDY)

Autor: Kiichiro Ninomiya, Tae Hata, Hiroshige Yoshioka, Kadoaki Ohashi, Akihiro Bessho, Shinobu Hosokawa, Nobuhisa Ishikawa, Masahiro Yamasaki, Takuo Shibayama, Keisuke Aoe, Toshiyuki Kozuki, Shingo Harita, Yutaka Ueda, Toshi Murakami, Nobukazu Fujimoto, Hiroyuki Yanai, Shinichi Toyooka, Minoru Takata, Katsuyuki Hotta, Katsuyuki Kiura, K. Gemba, G. Ikeda, M. Yasugi, E. Kurimoto, K. Nakano, T. Moritaka, K. Inoue, S. Miyoshi, N. Hamaguchi, R. Ito, Y. Sano, I. Takata, A. Mitani, T. Nishisaka, H. Shoda, A. Nishida, S. Tamamoto, K. Fujitaka, T. Masuda, S. Miyamoto, N. Hattori, K. Sugimoto, S. Fujii, Y. Ueda, M. Sakugawa, N. Fukamatsu, Y. Ogata, S. Bandoh, N. Kanaji, N. Takigawa, H. Yamane, N. Ochi, Y. Honda, M. Oka, M. Kittaka, T. Kubota, A. Yokoyama, T. Yokoyama, E. Sato, Y. Shiota, N. Horita, T. Kanematsu, Y. Awaya, A. Nakamasu, I. Murakami, S. Kuyama, K. Kudo, T. Tamura, T. Umeno, D. Morichika, K. Fujiwara, K. Sato, D. Harada, N. Nogami, K. Nishii, Y. Fuchimoto, T. Kishimoto, H. Kawai, K. Watanabe, K. Tokumo, T. Isobe, Y. Tsubata, M. Inoue, H. Ichikawa, Y. Nishioka, M. Hanibuchi, H. Goto, T. Sumikawa, M. Kodani, H. Suyama, H. Makino, N. Kinosita, E. Shimizu, H. Obata, H. Ikegami, K. Chikamori, T. Maeda, T. Kishino, H. Kamei, H. Ueoka, Y. Kunihiro, T. Kobayashi, K. Ueda, M. Hayashi, M. Kamiya, J. Murakami, A. Sato, E. Ichihara, T. Kubo, T. Ninomiya, T. Hirata, D. Minami, Y. Kato, H. Higo, G. Makimoto, Y. Toyota, N. Oda, M. Nakanishi, H. Kayatani, S. Senoo, H. Kano, H. Watanabe, T. Ando, T. Nakasuka, N. Hara, J. Itano, H. Nakashima, M. Tabata

Publikováno v: Chest. 156:357-366

Background Human epidermal growth factor 2 (HER2) is a potential driver oncogene. Although HER2-targeted precision therapy has been tested in non-small cell lung cancer (NSCLC), the demographic characteristics of HER2-positive NSCLC have not been sys

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::32fe2ca6b194183b37ade2ef10cd7369
https://doi.org/10.1016/j.chest.2019.01.011

A randomized trial of sodium alginate prevention of esophagitis in LA-NSCLC receiving chemoradiotherapy: OLCSG1401

Autor: Kenichiro Kudo, Shinobu Hosokawa, Yoshinobu Maeda, Toshihide Yokoyama, Kiichiro Ninomiya, Toshi Murakami, Toshiyuki Kozuki, Shoichi Kuyama, Isao Oze, Hiroshige Yoshioka, Kuniaki Katsui, Katsuyuki Kiura, Daijiro Harada, Akihiro Bessho, Katsuyuki Hotta, Masamoto Nakanishi, Tae Hata, Nagio Takigawa, Masayuki Yasugi

Publikováno v: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer. 29(9)

Radiation esophagitis is a critical adverse event that needs to be appropriately managed while administering thoracic irradiation. This trial aimed to investigate whether sodium alginate has preventative effects on esophagitis in patients with non-sm

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7c7c0ec96fe4575e679931c8afef7927
https://pubmed.ncbi.nlm.nih.gov/33649919

A randomized trial of sodium alginate prevention of radiation-induced esophagitis in patients with locally advanced NSCLC receiving concurrent chemoradiotherapy: OLCSG1401

Autor: Yoshinobu Maeda, Toshihide Yokoyama, Nagio Takigawa, K. Kiura, Masamoto Nakanishi, Kiichiro Ninomiya, Akihiro Bessho, Katsuyuki Hotta, T. Murakami, Kenichiro Kudo, A. Tanaka, Shoichi Kuyama, Isao Oze, Kuniaki Katsui, Masayuki Yasugi, Tae Hata, Toshiyuki Kozuki, Daijiro Harada, Shinobu Hosokawa

Publikováno v: Annals of Oncology. 30:v734-v735

Background Sodium alginate, which has been approved for treatment of gastritis in Japan, is highly viscous and thus remains in the esophageal mucosa for long periods, leading to a protective effect in the esophagus. The purpose of this trial was to i

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::b2ee7b855e766e06bc91655a8976df60
https://doi.org/10.1093/annonc/mdz265.052